|
TNGX Tango Therapeutics Inc 1819133 |
| Balance Sheet |
|
Current Assets
|
300,815,000 |
|
Assets
|
352,415,000 |
|
Current Liabilities
|
37,583,000 |
|
Liabilities
|
123,245,000 |
|
Equity
|
229,170,000 |
|
Shares Out
|
107,144,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-94,854,000 |
|
Investing Cash Flow
|
34,066,000 |
| Market Analysis |
Market Cap
|
921,441,880 |
|
Price
|
2.85 |
|
BVPS
|
2.14 |
|
PB
|
1.32 |
|
EPS
|
-1.11 |
|
PS
|
19.85 |
|
FCF
|
-60,788,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TNGX documents filed with the SEC.
TNGX Filings
Clear
